ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer, primarily focused on orphan and rare diseases. We are dedicated to our patients and committed to delivering medications that meet unmet needs in the current therapeutic landscape.
Location: United States, California, San Carlos
Member count: 51-200
Phone: +1 650-210-2900
Total raised: $29.84M
Founded date: 1997
Investors 2
| Date | Name | Website |
| - | Hercules C... | htgc.com |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.03.2007 | - | $29.84M | - | venturebea... |
Mentions in press and media 12
| Date | Title | Description | Category | Author | Source |
| 08.10.2021 | With FDA n... | The mainstay treatments for au... | - | - | medcitynew... |
| 28.09.2018 | UK biotech... | → BIA and Informa Pharma In... | - | John Carro... | endpts.com... |
| 14.02.2012 | HBM BioVen... | Timo Küng 14.00 Normal 0 21 ... | - | - | startuptic... |
| 06.01.2012 | GSK licens... | GSK, which has its U.S. headqu... | - | - | medcitynew... |
| 17.11.2008 | Cancer dru... | Mountain View, Calif.-based bi... | - | - | venturebea... |
| 06.10.2008 | ChemoCentr... | ChemoCentryx Inc., a biotech c... | - | - | venturebea... |
| 13.11.2007 | Chemokine-... | See our story about this Mount... | - | - | venturebea... |
| 12.11.2007 | IPOs: Biot... | ChemoCentryx files for $58M IP... | - | - | venturebea... |
| 22.03.2007 | ChemoCentr... | ChemoCentryx, a Mountain View,... | - | - | venturebea... |
| 25.08.2006 | ChemoCentr... | An obscure Mountain View biote... | - | - | venturebea... |
Show more